Miscellaneous Ob/Gyn conditions:

Indications for: PROSTIN E2

For the termination of pregnancy from the 12th through the 20th gestational weeks. For the evacuation of the uterine contents in the management of missed abortion or intrauterine fetal death up to 28 weeks of gestational age. Management of nonmetastatic gestational trophoblastic disease (benign hydatidiform mole).

Adult Dosage:

Insert one supp high into vagina. Remain in supine position for 10mins following insertion. May insert subsequent supp at 3–5hr intervals until abortion occurs. Continuous administration for more than 2 days is not recommended.

Children Dosage:

Not established.

PROSTIN E2 Contraindications:

Acute pelvic inflammatory disease. Active cardiac, pulmonary, renal or hepatic disease.

Boxed Warning:

Only use with strict adherence to recommended dosages. Should only be used by medically trained personnel in a hospital setting.

PROSTIN E2 Warnings/Precautions:

Not indicated if fetus in utero has reached the stage of viability. Not for use in cervical ripening or other indication in patients with term pregnancy. Asthma. Hypo-or hypertension. Anemia. Jaundice. Diabetes. Epilepsy. History of cardiac, renal, or hepatic disease. Cervicitis. Infected endocervical lesions. Acute vaginitis. Compromised (scarred) uteri. Remove supp if hypersensitivity reaction is suspected. Pregnancy.

PROSTIN E2 Classification:

Prostaglandin E2.

PROSTIN E2 Interactions:

Concomitant other oxytocic agents: not recommended.

Adverse Reactions:

Vomiting, transient pyrexia (see full labeling re: PGEs induced pyrexia vs. endometritis pyrexia), diarrhea, nausea, headache, chills, transient decrease in BP; MI in patients with history of CVD, hypersensitivity.

How Supplied: